Buy Ipamorelin 40 mg

€46.03

Ipamorelin, 40 mg, is a synthetic modified pentapeptide for receptor-signalling, analytical and in vitro laboratory research. Pharma Research .eu provides documented European supply subject to lot-specific purity, stereochemical and identity verification.

Category:
Description

Buy Ipamorelin, 40 mg, for Advanced Laboratory Research in Europe

Ipamorelin is a synthetic five-residue modified peptide used as a laboratory reagent in peptide analytics, receptor-signalling studies and controlled in vitro investigations. The commonly reported structure is Aib-His-D-2-Nal-D-Phe-Lys-NH₂, where Aib denotes α-aminoisobutyric acid and D-2-Nal denotes D-3-(2-naphthyl)alanine. Its reported formula is C₃₈H₄₉N₉O₅, with average molecular mass approximately 711.9 Da and CAS Registry Number 170851-70-4. Pharma Research .eu presents this 40 mg format for qualified European laboratory teams.pubchem.ncbi.nlm.nih+2

Uncompromising Purity and Analytical Characterisation

Ipamorelin should be specified as:

Aib-His-D-2-Nal-D-Phe-Lys-NH₂

The sequence contains several non-standard or stereochemically defined residues. Aib is α-aminoisobutyric acid, D-2-Nal is D-3-(2-naphthyl)alanine and D-Phe is D-phenylalanine. The C-terminal amide should also be stated explicitly. These features distinguish Ipamorelin from conventional linear pentapeptides and from related ghrelin-receptor ligands.

For laboratory procurement, the suitable target is ≥99.0% purity by RP-HPLC, subject to confirmation by the actual batch-specific certificate of analysis. Supplier quality documentation should also demonstrate intact-mass identity and, where necessary, stereochemical or sequence confirmation.artemispeptides+1

A complete CoA should include:

  • RP-HPLC purity percentage, analytical method and chromatogram.

  • LC-MS, ESI-MS or high-resolution MS identity confirmation.

  • Full sequence and stereochemical designation.

  • Confirmation of Aib, D-2-Nal, D-Phe and C-terminal amidation.

  • Molecular formula and molecular-mass assignment.

  • Free-peptide, acetate or other salt-form information.

  • Visual appearance of the lyophilised material.

  • Residual-solvent results from synthesis and purification.

  • Water or residual-moisture content, where measured.

  • Heavy-metal or elemental-impurity results where included in the quality programme.

  • Lot number, manufacture date, retest date and storage requirements.

The commonly reported formula is C₃₈H₄₉N₉O₅, with average molecular mass approximately 711.86–711.9 g/mol and monoisotopic mass near 711.3891 Da. CAS Registry Number 170851-70-4 and PubChem CID 9831659 are widely associated with Ipamorelin.pubchem.ncbi.nlm.nih+2

Ipamorelin is generally supplied as a white to off-white lyophilised powder. Visual inspection can identify gross discolouration, vial damage or visible contamination, but cannot establish identity or purity. Analytical release should combine appearance assessment with RP-HPLC and mass-spectral confirmation.

High purity is essential because incorrect stereochemistry, incomplete amidation, substitution errors, truncated sequences and residual synthesis materials can alter receptor binding, ionisation, chromatographic retention and assay response. A non-characterised peptide may be unsuitable for quantitative LC-MS, structure–activity studies or reproducible receptor-signalling experiments.

Principal Laboratory Applications and Research Methodologies

Ipamorelin is suitable for controlled laboratory research involving modified-peptide chemistry, analytical characterisation and receptor-signalling model development. All applications should be conducted by qualified personnel within an appropriately governed university, CRO, pharmaceutical R&D or analytical laboratory.

RP-HPLC and LC-MS method development. Ipamorelin can serve as a defined modified pentapeptide analyte for retention-time assignment, intact-mass confirmation, impurity profiling and sample-recovery studies. Its aromatic D-2-Nal residue may affect hydrophobic retention and requires appropriate chromatographic optimisation.

Sequence and stereochemistry verification. Laboratories may use high-resolution mass spectrometry, peptide mapping or orthogonal analytical methods to confirm Aib incorporation, D-2-Nal, D-Phe and terminal amidation. Mass alone may not distinguish every stereochemical variant, so the analytical strategy should match the research objective.

In vitro receptor-signalling assays. A verified Ipamorelin lot may be evaluated in controlled cell-free or cellular systems involving ghrelin-receptor-related signalling. Experimental designs should include vehicle controls, receptor-negative controls where relevant, concentration confirmation and independent peptide-integrity checks.

Stability and formulation research. Laboratories may investigate the influence of temperature, light, pH, oxidation, container material and freeze–thaw exposure. Stability-indicating methods should distinguish degradation from adsorption, precipitation, matrix effects and incomplete dissolution.

The 40 mg quantity corresponds to approximately 56.2 µmol using the reported molecular mass of 711.9 g/mol. If the material is supplied as a salt or contains significant water, the molar amount will differ. No working concentration should be stated without confirming the exact form, net content and final preparation volume.

Compound Stability, Optimal Storage, and Safe Handling Protocols

Ipamorelin should remain sealed in its lyophilised state until required for a validated laboratory procedure. Research references commonly recommend low-temperature, light-protected and moisture-controlled storage for the dry peptide. The lot-specific CoA should take precedence over generic catalogue guidance.kylopeptides+1

Recommended controls include:

  • Store unopened lyophilised Ipamorelin at approximately −20°C unless the CoA specifies otherwise.

  • Consider −80°C for extended archival storage where supported by the stability programme.

  • Keep the container tightly closed, dry and protected from direct light.

  • Allow a sealed vial to reach room temperature before opening to minimise condensation.

  • Use low-binding tubes where adsorption could affect recovery.

  • Prepare aliquots if repeated access is expected.

  • Store short-term aqueous solutions at 2–8°C only where validated.

  • Use frozen aliquots for longer-term solution storage when supported by stability data.

  • Avoid repeated freeze–thaw cycles.

  • Record solvent, concentration, preparation date, operator and storage history.

The hydrophobic D-2-Nal residue may affect solubility, adsorption and recovery, particularly at low concentrations. A clear solution should not automatically be assumed to retain its nominal concentration or molecular integrity without chromatographic confirmation.

Reconstitution should be performed using a validated laboratory procedure. Add the selected solvent gradually, allow the powder to hydrate and mix gently. Avoid vigorous agitation unless its compatibility has been demonstrated. If turbidity, precipitation or unexpected chromatographic changes occur, investigate the solution before use.

Handling should follow the current SDS and institutional chemical-risk assessment. Appropriate precautions generally include a certified fume hood or suitable local containment, nitrile gloves, safety goggles and a laboratory coat. Avoid aerosol generation and direct contact with the powder or solution. Dispose of contaminated materials through approved institutional chemical and laboratory-waste procedures.

Technical Specifications and Molecular Attributes

Attribute Specification
Product Ipamorelin, 40 mg
Common designation Ipamorelin; NNC 26-0161
Sequence Aib-His-D-2-Nal-D-Phe-Lys-NH₂
Residue count 5 modified amino-acid residues
IUPAC name Full systematic name should be confirmed on the CoA; sequence notation is preferred for procurement
CAS Registry Number 170851-70-4
Molecular formula C₃₈H₄₉N₉O₅
Average molecular mass Approximately 711.86–711.9 g/mol
Monoisotopic mass Approximately 711.3891 Da
Physical state and colour Lyophilised white to off-white powder
Solubility profile Aqueous reconstitution may be feasible; solvent and buffer compatibility require assay-specific validation
Typical purity Proposed target ≥99.0% by RP-HPLC; verify the actual lot-specific result
Identity testing LC-MS, ESI-MS or high-resolution MS
Long-term storage Typically −20°C, sealed and protected from light and moisture

The sequence, formula, molecular mass, CAS number and PubChem identity are supported by chemical and research references. The supplier’s CoA should control the final statement, particularly for stereochemistry, terminal amidation, salt form and net content.pubchem.ncbi.nlm.nih+3

Pharma Research .eu: Your Premier EU Vendor for High-Purity Reagents

Pharma Research .eu can position Ipamorelin as a documented European laboratory reagent for analytical chemists, biochemists and laboratory managers requiring a defined modified pentapeptide. The product file should include a batch-specific CoA, SDS, sequence and stereochemical designation, purity result, identity data, salt-form information and storage instructions.

Any claim that Pharma Research .eu operates an ISO 9001-certified quality-management system should be supported by a current certificate identifying the issuing body, scope and validity. Claims concerning discreet or temperature-controlled logistics across EU member states should likewise be verified for the destination, carrier route, packaging and applicable transport requirements.

A quality-focused supplier should be able to discuss:

  • Aib, D-2-Nal, D-Phe and C-terminal amidation.

  • Free-peptide versus acetate or other salt form.

  • RP-HPLC purity and LC-MS identity testing.

  • Residual solvents, moisture and elemental-impurity reporting.

  • Packaging configuration and container-closure integrity.

  • Solvent compatibility and adsorption controls.

  • Storage, transport and documentation requirements.

Pharma Research .eu should therefore be described as a potential European source for research-grade Ipamorelin, with vendor-specific certification and logistics claims verified through current records. The material is intended strictly for controlled laboratory research and analytical use by qualified personnel under applicable institutional procedures.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Buy Ipamorelin 40 mg”

Your email address will not be published. Required fields are marked *

Shipping & Delivery

MAECENAS IACULIS

Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.

ADIPISCING CONVALLIS BULUM

  • Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
  • Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
  • Diam parturient dictumst parturient scelerisque nibh lectus.

Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.